[HTML][HTML] Evolving treatment paradigms for PCV
BJ Fenner, CMG Cheung, SS Sim, WK Lee… - Eye, 2022 - nature.com
Polypoidal choroidal vasculopathy (PCV) is a subtype of neovascular AMD (nAMD) that
accounts for a significant proportion of nAMD cases worldwide, and particularly in Asia …
accounts for a significant proportion of nAMD cases worldwide, and particularly in Asia …
Multimodal imaging comparison of polypoidal choroidal vasculopathy between Asian and Caucasian populations
Purpose Differences in multimodal imaging features between Asian and Caucasian eyes
may contribute to our understanding of the etiology of the polypoidal choroidal vasculopathy …
may contribute to our understanding of the etiology of the polypoidal choroidal vasculopathy …
[HTML][HTML] Intravitreal anti-vascular endothelial growth factor and combined photodynamic therapy for pachychoroid neovasculopathy: long-term treatment outcomes
N Tanaka, K Azuma, S Aoki, K Kitamoto, K Ueda… - Graefe's Archive for …, 2024 - Springer
Purpose To examine the long-term visual outcomes after initial treatment with combined
photodynamic therapy (PDT) or aflibercept treat-and-extend (TAE) monotherapy in patients …
photodynamic therapy (PDT) or aflibercept treat-and-extend (TAE) monotherapy in patients …
Polypoidal choroidal vasculopathy features vary according to subfoveal choroidal thickness
JM Jordan-Yu, KYC Teo, U Chakravarthy, A Gan… - Retina, 2021 - journals.lww.com
Purpose: To evaluate associations between choroidal thickness and features of polypoidal
choroidal vasculopathy (PCV) lesions based on multimodal imaging. Methods: This cross …
choroidal vasculopathy (PCV) lesions based on multimodal imaging. Methods: This cross …
[HTML][HTML] Real world experience of the treatment outcome between photodynamic therapy combined with ranibizumab and aflibercept monotherapy in polypoidal …
To provide real-world experiences of treating polypoidal choroidal vasculopathy (PCV)
patients with photodynamic therapy (PDT) plus intravitreal injection of ranibizumab or …
patients with photodynamic therapy (PDT) plus intravitreal injection of ranibizumab or …
Three-year outcome of photodynamic therapy combined with VEGF inhibitor for pachychoroid neovasculopathy
Y Nomura, S Aoki, K Kitamoto, K Ueda… - Graefe's Archive for …, 2024 - Springer
Background Long-term results of photodynamic therapy (PDT) combined with vascular
endothelial growth factor (VEGF) inhibitors for pachychoroid neovasculopathy (PNV) are not …
endothelial growth factor (VEGF) inhibitors for pachychoroid neovasculopathy (PNV) are not …
Long-term predictors of anti-VEGF treatment response in patients with neovascularization secondary to CSCR: a longitudinal study
GM Cozzupoli, R Sacconi, B Tombolini… - Graefe's Archive for …, 2024 - Springer
Purpose To identify the baseline predictors of anti-VEGF treatment response at 3 years in
patients affected by choroidal neovascularization (CNV) secondary to central serous …
patients affected by choroidal neovascularization (CNV) secondary to central serous …
Quantitative analysis of branching neovascular networks in polypoidal choroidal vasculopathy by optical coherence tomography angiography after photodynamic …
Purpose To study serial changes in branching neovascular networks (BNN) by using optical
coherence tomography angiography (OCTA) in patients with polypoidal choroidal …
coherence tomography angiography (OCTA) in patients with polypoidal choroidal …
[HTML][HTML] Choroidal Morphology on Ultra-Widefield Indocyanine Green Angiography and Response to Aflibercept in Pachychoroid Neovasculopathy
SY Han, SH Lee, P Lee, H Ra, J Baek - Pharmaceuticals, 2023 - mdpi.com
Purpose: This study assessed the relationship between the choroidal morphology and short-
term response to aflibercept treatment in pachychoroid neovasculopathy (PNV). Methods …
term response to aflibercept treatment in pachychoroid neovasculopathy (PNV). Methods …
Locational agreement of near-infrared autofluorescence with choroidal vascular hyperpermeability in central serous chorioretinopathy
K Azuma, Y Nomura, K Kitamoto, Y Hashimoto… - Retina, 2022 - journals.lww.com
Purpose: To characterize the findings of eyes with choroidal vascular hyperpermeability
(CVH), a hallmark of central serous chorioretinopathy, using multimodal imaging and …
(CVH), a hallmark of central serous chorioretinopathy, using multimodal imaging and …